Index by author

September 01, 1996; Volume 63,Issue 5

  1. Bacon, Bruce R.

    1. Interpreting serologic tests for hepatitis C virus infection: balancing cost and clarity
      Geoffrey S. Long, MD, Bruce R. Bacon, MD and Adrian M. Di Bisceglie, MD
      Cleveland Clinic Journal of Medicine September 1996, 63 (5) 264-268;

      ELISA screening tests for HCV have unacceptably high false-positive rates. Newer tests are more accurate, but costly.

  2. Braverman, Lewis

    1. The Different Faces of Thyrotoxicosis
      Lewis Braverman, MD
      Cleveland Clinic Journal of Medicine September 1996, 63 (5) 259-261;

      Hyperthyroidism manifests itself in many ways, but clinical cues and the radioactive iodine uptake test can narrow the diagnosis.

  3. Brouhard, Ben H.

    1. Prevention of insulin-dependent diabetes mellitus: an overview of three trials
      Desmond A. Schatz, MD, Douglas G. Rogers, MD and Ben H. Brouhard, MD
      Cleveland Clinic Journal of Medicine September 1996, 63 (5) 270-274;

      Clinicians are eagerly awaiting the results of three large-scale trials using different approaches to prevent IDDM.

  4. Clough, John D.

    1. In Reply: Health quality data
      John D. Clough, MD
      Cleveland Clinic Journal of Medicine September 1996, 63 (5) 304;
    2. Can medicine serve both humanity and the bottom line?
      John D. Clough, MD
      Cleveland Clinic Journal of Medicine September 1996, 63 (5) 257-258;

      Will the commitment to public health and community service be lost in the shift toward for-profit medicine?

  5. Di Bisceglie, Adrian M.

    1. Interpreting serologic tests for hepatitis C virus infection: balancing cost and clarity
      Geoffrey S. Long, MD, Bruce R. Bacon, MD and Adrian M. Di Bisceglie, MD
      Cleveland Clinic Journal of Medicine September 1996, 63 (5) 264-268;

      ELISA screening tests for HCV have unacceptably high false-positive rates. Newer tests are more accurate, but costly.

  6. Domen, Ronald E.

    1. Preoperative autologous blood donation: clinical, economic, and ethical issues
      Ronald E. Domen, MD
      Cleveland Clinic Journal of Medicine September 1996, 63 (5) 295-300;

      Autologous blood transfusion is not without risk. The expense involved in reducing the use of allogeneic blood raises a number of ethical issues.

  7. Foote, Caroline B.

    1. Strategies for managing atrial fibrillation
      Michael S. Katcher, MD, Caroline B. Foote, MD, Munther Homoud, MD, Paul J. Wang, MD and N.A. Mark Estes, MD
      Cleveland Clinic Journal of Medicine September 1996, 63 (5) 282-294;

      The limitations of current therapies for atrial fibrillation are forcing a rethinking of how they should be used.

  8. Goldman, Morton P.

    1. Contemporary issues in cost-effective drug therapy
      Bruce D. McWhinney, PharmD and Morton P. Goldman, PharmD
      Cleveland Clinic Journal of Medicine September 1996, 63 (5) 261-263;

      There is more to controlling pharmacy costs than choosing the least expensive drug. Preventing medication errors and reducing overall costs is key.

  9. Harper, Dwain L.

    1. Health quality data
      John C. Morley and Dwain L. Harper, DO
      Cleveland Clinic Journal of Medicine September 1996, 63 (5) 303-304;

  10. Hoffman, Gary S.

    1. Interpreting serologic tests for hepatitis C virus infection: balancing cost and clarity
      Geoffrey S. Long, MD, Bruce R. Bacon, MD and Adrian M. Di Bisceglie, MD
      Cleveland Clinic Journal of Medicine September 1996, 63 (5) 264-268;

      ELISA screening tests for HCV have unacceptably high false-positive rates. Newer tests are more accurate, but costly.

« Previous (Pages : 1 2 3 ... 3) Next »
Back to top

In this issue